Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms.

about

Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms.

Item

http://www.wikidata.org/entity/Q51748677

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Metformin exerts multitarget a ...... myeloproliferative neoplasms.

@en

Metformin exerts multitarget a ...... myeloproliferative neoplasms.

@nl

type

Item

label

Metformin exerts multitarget a ...... myeloproliferative neoplasms.

@en

Metformin exerts multitarget a ...... myeloproliferative neoplasms.

@nl

prefLabel

Metformin exerts multitarget a ...... myeloproliferative neoplasms.

@en

Metformin exerts multitarget a ...... myeloproliferative neoplasms.

@nl

P1476

Metformin exerts multitarget a ...... myeloproliferative neoplasms.

@en

P2093

Ana Paula Nunes Rodrigues Alves

http://www.w3.org/2001/XMLSchema#string

Belinda Pinto Simões

http://www.w3.org/2001/XMLSchema#string

Brian J Druker

http://www.w3.org/2001/XMLSchema#string

Bruna Alves Fenerich

http://www.w3.org/2001/XMLSchema#string

Christopher A Eide

http://www.w3.org/2001/XMLSchema#string

Cristina E Tognon

http://www.w3.org/2001/XMLSchema#string

Jaqueline Cristina Fernandes

http://www.w3.org/2001/XMLSchema#string

Juan Luiz Coelho-Silva

http://www.w3.org/2001/XMLSchema#string

Lorena Lôbo de Figueiredo Pontes

http://www.w3.org/2001/XMLSchema#string

Luciane Carla Alberici

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms

Repurposing metformin for cancer treatment: current clinical studies

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

Mitochondria and cancer

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Ba/F3 cells and their use in kinase drug discovery.

Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles.

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.

Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

P2888

s41419-017-0256-4

P304

311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41419-017-0256-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eduardo Magalhães Rego

João Agostinho Machado-Neto

Fabiola Traina

Priscila Santos Scheucher

Carlos R P Dechandt

P577

2018-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101165103

http://www.w3.org/2001/XMLSchema#string

P698

29472557

http://www.w3.org/2001/XMLSchema#string

P921

metformin

P932

5833553

http://www.w3.org/2001/XMLSchema#string